Bexorg closes a $23 million Series A funding round to enhance CNS drug discovery using a unique platform that restores activity in postmortem brains.
Amount Raised
$23 Million
Round Type
Series A
New HavenBiotechnologyHealth CareresearchInvestors
Description
New Haven-based biotech Bexorg has closed a $23 million Series A funding round to expand its whole-human brain research platform. The company aims to transform CNS drug discovery by restoring molecular and metabolic activity to postmortem human brains. Founded by Yale neuroscientists, Bexorg's innovative approach seeks to address high failure rates in CNS drug trials. The funding will support their research into neurodegenerative diseases like Alzheimer’s and Parkinson’s.
Quick answer
Bexorg raised $23 Million in a Series A round, dated October 16, 2025. Investors: Amplify Partners, E1 Ventures, E1 Ventures- Proceeds, Connecticut Innovations, Starbloom Capital and Engine Ventures. Bexorg is based in New Haven, Connecticut, United States.
- How much did Bexorg raise?
- Bexorg raised $23 Million in a Series A round on October 16, 2025.
- Who invested in Bexorg?
- Amplify Partners, E1 Ventures, E1 Ventures- Proceeds, Connecticut Innovations, Starbloom Capital and Engine Ventures are named as investors in this round.
- What does Bexorg do?
- Bexorg is a biotech company based in New Haven that focuses on transforming central nervous system drug discovery.
- Where is Bexorg based and how big is it?
- Bexorg is based in New Haven, Connecticut, United States. Fundz records about 29 employees.
- Who are the decision-makers at Bexorg?
- Fundz holds 1 contact at Bexorg, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Bexorg that raised within 45 days of this round, from Fundz verified event records.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- Hepta raised $6.7M (Seed) on November 5, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
- Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
- Grail raised $325M (Post-IPO Equity) on October 20, 2025.
Who to call at Bexorg, and when
A new round usually means Bexorg is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bexorg raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bexorg, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bexorg. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bexorg raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansBexorg raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.